pyrrolidonecarboxylic acid has been researched along with Memory Disorders in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hook, G; Hook, V; Kindy, M | 1 |
| Erden, F; Holubová, K; Horáček, J; Höschl, C; Mutlu, O; Páleníček, T; Pinterová, N; Šíchová, K; Stuchlík, A; Valeš, K | 1 |
| Brusco, LI; Cardinali, D; Castaño, EM; Cuello, AC; Do Carmo, S; Galeano, P; Gevorkian, G; Martino Adami, PV; Morelli, L; Olivar, N; Pagano, ES; Quijano, C; Rabossi, A; Radi, R; Reyes Toso, C; Wallinger, ML | 1 |
| Addolorato, G; Bertini, M; Ferrulli, A; Gasbarrini, G; Leggio, L; Vonghia, L | 1 |
| Jiang, XG; Lu, W; Xie, YL | 1 |
| Chen, J; Gao, H; Gao, X; Hu, K; Jiang, X; Lu, W; Pang, Z; Zhang, C; Zhu, C | 1 |
| Kameyama, T; Nabeshima, T; Narimatsu, H; Nishimura, K; Senzaki, K; Tanaka, T; Yamada, K | 1 |
| Hirate, K; Nishikawa, T; Ohnishi, Y; Sato, T; Tanaka, K; Teramoto, T | 1 |
| Hori, E; Miyake, N; Nishijo, H; Ono, T; Tamura, R; Uwano, T | 1 |
| Grioli, S; Lomeo, C; Quattropani, MC; Spignoli, G; Villardita, C | 1 |
2 review(s) available for pyrrolidonecarboxylic acid and Memory Disorders
| Article | Year |
|---|---|
Cathepsin B Deficiency Improves Memory Deficits and Reduces Amyloid-β in hAβPP Mouse Models Representing the Major Sporadic Alzheimer's Disease Condition.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Cathepsin B; Disease Models, Animal; Memory Disorders; Mice; Mice, Transgenic; Pyrrolidonecarboxylic Acid | 2023 |
Acute alcohol intoxication.
Topics: Acute Disease; Alcohol Deterrents; Alcoholic Intoxication; Ataxia; Coma; Diagnosis, Differential; Drug Combinations; Emergency Medical Services; Ethanol; Evidence-Based Medicine; Fluid Therapy; Gait; Humans; Impulsive Behavior; Memory Disorders; Mood Disorders; Pyridoxine; Pyrrolidonecarboxylic Acid; Randomized Controlled Trials as Topic; Stupor; Treatment Outcome | 2008 |
1 trial(s) available for pyrrolidonecarboxylic acid and Memory Disorders
| Article | Year |
|---|---|
Pyroglutamic acid improves the age associated memory impairment.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Form Perception; Humans; Memory Disorders; Middle Aged; Psychomotor Performance; Pyrrolidinones; Pyrrolidonecarboxylic Acid; Randomized Controlled Trials as Topic | 1990 |
7 other study(ies) available for pyrrolidonecarboxylic acid and Memory Disorders
| Article | Year |
|---|---|
Effects of the adipokinetic hormone/red pigment-concentrating hormone (AKH/RPCH) family of peptides on MK-801-induced schizophrenia models.
Topics: Animals; Anti-Anxiety Agents; Disease Models, Animal; Dizocilpine Maleate; Insect Hormones; Male; Memory; Memory Disorders; Neuropeptides; Neuroprotective Agents; Oligopeptides; Peptides; Pyrrolidonecarboxylic Acid; Rats; Rats, Long-Evans; Rats, Wistar; Schizophrenia | 2018 |
Worsening of memory deficit induced by energy-dense diet in a rat model of early-Alzheimer's disease is associated to neurotoxic Aβ species and independent of neuroinflammation.
Topics: Adiposity; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Cognition; Diet, Western; Disease Models, Animal; Energy Metabolism; Gene Deletion; Hippocampus; Humans; Inflammation; Male; Memory Disorders; Pyrrolidonecarboxylic Acid; Rats; Rats, Transgenic | 2017 |
Improvement of cationic albumin conjugated pegylated nanoparticles holding NC-1900, a vasopressin fragment analog, in memory deficits induced by scopolamine in mice.
Topics: Animals; Arginine Vasopressin; Avoidance Learning; Drug Carriers; Drug Delivery Systems; Male; Memory; Memory Disorders; Mice; Nanostructures; Nootropic Agents; Oligopeptides; Particle Size; Peptide Fragments; Polyethylene Glycols; Pyrrolidonecarboxylic Acid; Random Allocation; Scopolamine; Serum Albumin, Bovine | 2006 |
Preparation and brain delivery property of biodegradable polymersomes conjugated with OX26.
Topics: Animals; Antibodies, Monoclonal; Area Under Curve; Biological Availability; Brain; Coumarins; Cryoelectron Microscopy; Electron Probe Microanalysis; Lactones; Learning Disabilities; Maze Learning; Memory Disorders; Microscopy, Immunoelectron; Nanocapsules; Oligopeptides; Particle Size; Polyesters; Polyethylene Glycols; Polymers; Pyrrolidonecarboxylic Acid; Rats; Rats, Sprague-Dawley; Receptors, Transferrin; Scopolamine | 2008 |
NC-1900, an active fragment analog of arginine vasopressin, improves learning and memory deficits induced by beta-amyloid protein in rats.
Topics: Amyloid beta-Peptides; Animals; Arginine Vasopressin; Behavior, Animal; Choline O-Acetyltransferase; Frontal Lobe; Hippocampus; Injections, Intraventricular; Learning Disabilities; Male; Memory Disorders; Oligopeptides; Peptide Fragments; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar | 1998 |
[The ameliorating effects of a novel NC-1900 on impairments of learning/memory caused by glutamic acid].
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Arginine Vasopressin; Avoidance Learning; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Glutamic Acid; Glycine; Kainic Acid; Learning Disabilities; Male; Memory Disorders; Mice; Mice, Inbred Strains; N-Methylaspartate; Neuromuscular Depolarizing Agents; Oligopeptides; Pyrrolidonecarboxylic Acid; Rats; Rats, Sprague-Dawley; Resorcinols | 1999 |
Effects of a novel arginine-vasopressin derivative, NC-1900, on the spatial memory impairment of rats with transient forebrain ischemia.
Topics: Amnesia; Animals; Brain Ischemia; Disease Models, Animal; Hippocampus; Learning; Male; Memory Disorders; Oligopeptides; Prosencephalon; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar; Vasopressins | 2002 |